Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI)

Pharmaceutical Preparations

https://www.maravai.com

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/20/2020

Market Cap

2,374,270,070

Shares Outstanding

132,190,000

Weighted SO

132,188,632

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ROIV --.--%

KRYS --.--%

RXDX --.--%

AKRO --.--%

APLS --.--%

HALO --.--%

AGIO --.--%

INSM --.--%

CERE --.--%

Beta

0.0180

Last Div

0.0000

Range

4.52-11.555

Chg

1.7800

Avg Vol

2134801

Mkt Cap

2374270070

Exch

NASDAQ

Country

US

Phone

858 546 0004

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

8.5226

EV Multiple

342.8580

P/FV

3.0313

Div Yield %

0.0000

P/E

-10.0274

PEG

-0.2831

Payout

0.0000

Current Ratio

9.9977

Quick Ratio

9.2786

Cash Ratio

8.3611

DSO

51.4369

DIO

110.5600

Op Cycle

161.9968

DPO

28.1166

CCC

133.8802

Gross Margin

0.4158

Op Margin

-0.1589

Pretax Margin

2.1404

Net Margin

-0.4741

Eff Tax Rate

1.2721

ROA

-0.0912

ROE

-0.2962

ROCE

-0.0321

NI/EBT

-0.2215

EBT/EBIT

-13.4690

EBIT/Rev

-0.1589

Debt Ratio

0.3664

D/E

1.2138

LT Debt/Cap

0.5420

Total Debt/Cap

0.5483

Int Coverage

-10.4561

CF/Debt

0.0583

Equity Multi

3.3131

Rec Turnover

7.0961

Pay Turnover

12.9817

Inv Turnover

3.3014

FA Turnover

1.6833

Asset Turnover

0.1924

OCF/Share

0.2276

FCF/Share

-0.1246

Cash/Share

4.2194

OCF/Sales

0.1110

FCF/OCF

-0.5472

CF Coverage

0.0583

ST Coverage

2.3306

CapEx Coverage

0.6463

Div&CapEx Cov

0.6463

P/BV

3.0313

P/B

3.0313

P/S

8.5226

P/E

-10.0274

P/FCF

-140.3150

P/OCF

42.8309

P/CF

42.8309

PEG

-0.2831

P/S

8.5226

EV Multiple

342.8580

P/FV

3.0313

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 09, 01:00 MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm GlobeNewswire Inc. Apr 29, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AppLovin, Maravai, e.l.f. Beauty, and Skyworks Solutions and Encourages Investors to Contact the Firm GlobeNewswire Inc. Apr 22, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AppLovin, Maravai, e.l.f. Beauty, and Manhattan Associates and Encourages Investors to Contact the Firm GlobeNewswire Inc. Apr 18, 00:47 ROSEN, A LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI GlobeNewswire Inc. Apr 10, 22:53 MRVI Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) GlobeNewswire Inc. Apr 08, 21:44 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI GlobeNewswire Inc. Apr 07, 20:49 Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman GlobeNewswire Inc. Apr 06, 14:51 Maravai LifeSciences Holdings, Inc. (MRVI) Investors: May 5, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP GlobeNewswire Inc. Apr 05, 21:23 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI Benzinga Apr 03, 22:15 MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire Inc. Mar 30, 17:00 ROSEN, LEADING TRIAL ATTORNEYS, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI GlobeNewswire Inc. Mar 24, 02:28 Class Action Reminder for MRVI Investors: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors of Securities Fraud Class Action Lawsuit GlobeNewswire Inc. Mar 15, 20:10 Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit GlobeNewswire Inc. Mar 15, 14:32 MRVI INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire Inc. Mar 14, 22:42 ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI GlobeNewswire Inc. Mar 08, 05:30 Maravai LifeSciences Holdings, Inc. Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against MRVI GlobeNewswire Inc. Mar 04, 22:50 MRVI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead the Maravai Class Action Lawsuit GlobeNewswire Inc. Feb 28, 00:55 Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman GlobeNewswire Inc. Feb 27, 01:00 Kirby McInerney LLP Announces Investigation Against Maravai Lifesciences Holdings, Inc. (MRVI) on Behalf of Investors Benzinga Dec 12, 13:56 Stocks Edge Higher, 'Fear Index' Plummets To Nearly 3-Year Lows Ahead Of Fed Meeting: What's Driving Markets Tuesday?

Revenue Product Segmentation